Rachel , John , and Michael: Cardiovascular and Renal Calcification and Bone: A comparison of the effect of Dietary Fatty Acids.

Introduction

Ectopic calcification has long been found in autopsy studies and is now regularly detected with multi-detector computed tomography (MDCT) and, when located in the cardiovascular (CV) system, has become known as a form of subclinical atherosclerosis. The initiation of ectopic calcification resembles the process of osteogenesis, involving the same cells, proteins and cytokines. Studies have shown osteoblast- and osteoclast-like cells and bone matrix proteins in the arterial wall1, hydroxyapatite (calcium phosphate) deposition and, in cases of more severe calcification, fully formed bone is seen in arteries and valves2. Fracture incidence and low BMD have frequently been shown to correlate with CV calcification3–4 and plaque burden5, particularly in postmenopausal women, and the two conditions have several shared risk factors and biomarkers6. Within arteries, calcification may occur in the tunica media, particularly in chronic kidney disease and diabetes mellitus, or as a thick fibrous atheroma cap7–8. Although this covering of the atheroma may help to prevent plaque rupture, its presence has also been correlated with acute coronary syndrome2. Despite the apolipoprotein E4 genotype being correlated with dyslipidaemia and atherosclerosis, it is not associated with aortic calcification or BMD9. It remains unclear as to why ectopic calcification forms in the first place, with one theory suggesting that calcium phosphate is taken out of bone and deposited in soft tissue rather than being incorporated in bone or excreted in urine, as would normally be the case.

Diet is known to play an important role in the development of atherosclerosis risk factors, with fat intake thought to be particularly important via the pathogenesis of dyslipidaemia. A diet high in saturated and trans fats is thought to contribute to the development of atheroma10–11, while certain omega-6 (ω6) polyunsaturated fatty acids (PUFAs), found mainly in plant oils, may also be atherogenic12. By contrast, monounsaturated fatty acids (MUFAs) from olive oil and omega-3 (ω3) PUFAs from fish oil have been found to reduce atherosclerosis13–14. In particular, a lower ratio of dietary ω3 to ω6 is a critical risk factor for acute coronary syndrome15. Within each PUFA family (Figure 1), there is an intricate pathway of metabolites, dependent upon shared enzymes. In order to explore another possible similarity between ectopic calcification and bone mineralisation, this article compares the effect of dietary fats on both ectopic calcification and bone mineralisation and, where also assessed, other measures of sub-clinical atherosclerosis.

In vitro studies

While many in vitro studies have been carried out on ectopic calcification in order to elucidate its pathogenesis, few have involved fats and oils. In human arterial endothelial cells, a magnesium deficiency allowed entry of the trans fatty acids linoelaidic and elaidic acids into cells, which increased the incorporation of calcium and may thereby increase arterial calcification16. Omega-3 fats, however, inhibited the mineralization of vascular cells and activity of alkaline phosphatase (ALP), a marker of bone formation, with much of the benefit deriving from docosahexaenoic acid (DHA)17. In human osteoblast-like cells, arachidonic acid (AA), but not eicosapentaenoic acid (EPA) or oleic acid, reduced bone cell adhesion, while EPA and oleic acid, but not AA, increased gene expression of type I collagen and fibronectin, encouraging bone growth18. Similarly, an optimum ratio of 4:1 linoleic acid to alpha-linolenic acid increased osteoblastogenesis, the effect being enhanced by the addition of conjugated linoleic acid and calcium19.

Animal studies

Ectopic calcification

Dietary cholesterol is regularly used, often with other factors, to induce atherosclerotic lesions and/or calcification of the arteries and heart valves in animal models of hypercholesterolaemia20; the calcification tends to appear later than atherosclerotic lesions20, while arteries may calcify before valves21. Dietary cholesterol appears to induce only atheroma calcification, with no sign of media calcification22. The necessary conditions for arterial or renal calcification induction appear to be a high fat diet plus cholesterol, while high fat alone or a low fat diet with cholesterol failed to induce calcification23–24, although high fat actually reduced renal calcification25. Finally, a study of bone and renal calcification found that a high fat diet increased serum ALP and renal calcium phosphate deposition, with significant bone calcium loss and increased urinary calcium excretion24.

Among PUFAs, a diet rich in linoleic acid (LA) decreased heart valve and gastric and renal artery calcification26, with no difference in severity of calcification between a high or low LA diet25. Fish oil and gamma-linolenic acid (GLA), alone or combined, significantly reduced renal calcification, with a possible synergistic effect between the two27. EPA could also limit induced abdominal aorta medial (but not iliac) calcification by lowering the expression of osteogenic markers and suppressing matrix metalloproteinase-9 activity28, although monoester EPA plus LA increased renal and aortic calcification, while high dose EPA given with antioxidant lipoic acid prevented calcification29.

Bone

Both a high fat diet, regardless of its constituents, and a deficiency can be detrimental to bone30–31, suggesting that fatty acid intake demonstrates a U-shaped dose/response curve. Animal saturated fats can be harmful to bone and reduce calcium absorption32, although coconut oil (a saturated fat) appears to increase BMD and bone strength33, while olive oil (a MUFA) prevented bone loss in ovariectomised rats34. Among PUFAs, both LA and ALA can separately strengthen bone35 but may be more effective when supplemented together36. Where oils rich in LA (safflower, soyabean, sunflower, sesame and corn oils) and flaxseed oil (containing principally ALA) are compared, there is either no difference in their positive effect on bone or ALA is more beneficial37–38. When LA was compared to fish oil (EPA + DHA), fish oil resulted in consistently improved bone parameters39–40. These properties of fish oil may be stronger in ovariectomised but not sham-operated animals41 but can also increase newly formed bone and bone thickness in males42. Only in one study did fish oil give significantly degraded bone properties43 but the fish oil dose was extremely high.

Figure 1

Metabolism of polyunsaturated fatty acids.

icjf.2014.1.3.128.g001.jpg

The balance between ω6 and ω3 appears to be critical, with an ω6:ω3 ratio of 5:1 giving significantly higher BMC than a 10:1 ratio, with optimum results when the total fat intake was low44. Another study found that an LA /fish oil ratio of 3:7 gave the highest bone formation rate45, while incorporation of DHA into tissues showed a U-shaped curve, with the maximum incorporation occurring between the LA:ALA ratios of 4:1 and 2:146. Although some studies have shown that EPA, with or without DHA, can be effective47, others suggest that it is DHA that is the active constituent with respect to bone48, with high dose EPA lowering BMD49. The metabolites of LA may be more effective than LA itself. Studies show that higher ratios of GLA:EPA were more beneficial, with one showing an optimum ratio of 3:150, although DHA was more effective than both51. AA, also found in meat, could reduce markers of bone resorption and raise BMC52, with an optimum ratio for AA:DHA of 5:1, although this ratio was only beneficial at low levels of intake53.

Human epidemiological studies

Ectopic calcification

In the only study to consider dietary cholesterol, intake was positively associated with the CAC score in Korean men, whereas total fat was not associated54. Studies of the percentage of energy represented by fat intake and CAC prevalence or extent show mixed results, while a large study showed that a food pattern high in total, saturated and trans fats was positively associated with CAC presence and extent and cIMT55, although other dietary factors may have been confounding. Total and saturated fat intake were also positively correlated with CAC incidence among type 1 diabetics, although this was no longer significant after adjustment for conventional CV risk factors56. A small study of Korean haemodialysis patients, particularly prone to ectopic calcification, found no association of intake of saturated fat or ω6 PUFAs and calcification of the extremities or the abdominal aorta57. A prospective study of premenopausal women showed that although there was no association between total fat intake and arterial calcification or the carotid plaque index, saturated fat intake was positively correlated with coronary but not aortic calcification or the carotid plaque index, after adjustment for risk factors55. There have been no studies of MUFAs and ectopic calcification.

A large US study investigated intake of long chain ω3 PUFAs and non-fried fish and found no association with CAC presence, although there was a significant inverse association with cIMT58. Similarly, a comparison study between Japanese and American men showed a significant inverse association between EPA and DHA intake and CAC and cIMT but after adjustment for CVD risk factors, only the relationship with cIMT in Japanese men continued. The median intake of EPA+DHA in the lowest tertile in Japanese men was still greater than that of the highest tertile in American men, which may explain the protective effect for cIMT in Japanese men only.59 In a further comparison of middle-aged Japanese and Caucasian men, Japanese men had a higher level of serum long chain ω3 PUFAs and a significantly lower incidence of CAC compared to Caucasians, even after adjusting for age and conventional CV risk factors60. Another Japanese study of acute myocardial infarction (MI) patients found that in multivariate analysis, only serum log EPA was inversely correlated with the CAC score, although serum log EPA, DHA and the ω-6:EPA ratios were inversely correlated with soft plaque scores61. A large Dutch prospective study found that subjects with a fish intake >19g/d compared to zero had a significantly lower incidence of CAC score of 11-400, the association being entirely attributable to women; the association with CAC score >400 was not significant in either gender. This inverse association in women became non-significant after adjustment for triglycerides, although adjustment for hypertension and other blood lipids did not change the association. Curiously, there was no association with intake of EPA+DHA, although the majority of the fish consumed was cod which does not contain high long chain ω3 fats.62

Bone

Epidemiological studies of total and saturated fat intake show mixed results with respect to BMD and fracture risk63–64, with saturated fat being detrimental only at higher intakes65. Mixed results were also seen in investigations of MUFA intake64, although when analysed by source, olive oil intake was positively associated with BMD63, but where MUFAs were principally derived from animal sources, there was no association65. Macdonald et al showed that intake of mainly animal-derived MUFAs was only adversely associated with BMD in the lowest tertile of calcium intake66.

There is also no clear conclusion from the results of studies of PUFA intake, with most showing no association, although some benefit was seen with higher intake of ω3 PUFAs67–68. Nevertheless, a higher intake of ω6 PUFAs can increase fracture risk and lower BMD63,68, although AA may be protective in men69. There appears to be an interaction between ω6 and ω3 PUFAs. Fish oil intake above the median resulted in lower BMD among those with LA intake above the median70 and higher BMD among those with the highest AA intake71. Nevertheless, high AA with low fish oil intake may reduce BMD71. Again, increased PUFA intake was associated with greater BMD loss only in those in the lowest tertile of calcium intake66. In the many studies investigating total fish intake, there is either a beneficial association with BMD or fracture risk or no relationship70–71; the correlation may only be with oily fish intake70,72. Two studies have found that eating fish 3-4 times per week was associated with reduced risk but there was no association with greater fish consumption71,73.

Human intervention studies

There are no intervention studies of fatty acids and ectopic calcification but several related to biomarkers of bone formation or resorption, which may equally apply to bone or ectopic calcification. Many of these involve multiple interventions, making it impossible to isolate the effect of any one fatty acid. In general, lower saturated fat intake and a lower ω6:ω3 ratio proved beneficial74, with fish, fish oil and oleic acid increasing bone formation markers75 and reducing resorption markers76. Some studies showed no significant difference from the placebo77–78 but one reason for this may be that the placebo is usually an oil, which may itself have a beneficial effect79.

Comparison of the effect of fats on CV calcification versus other measures of subclinical atherosclerosis

High intake of saturated, trans and total fats appears to be positively correlated with both CAC presence and cIMT, although fish and fish oil intake may show no significant association with CAC after adjustment for risk factors but a significant protective effect against cIMT and soft plaque scores. This is particularly evident in comparison studies of Japanese and American men, which show a significant inverse association between fish oil intake or serum EPA/DHA and CAC presence or extent and cIMT in univariate analysis but mixed results for CAC after adjustment for CVD risk factors. This suggests that fish oil may operate by lowering CV risk factors, which has more impact on cIMT than on CAC, and was borne out by one of the MESA studies which showed that the inverse association of BMD with CAC was stronger in women without dyslipidaemia, arguing against the hypothesis that dyslipidaemia is the key factor responsible for the inverse association of BMD with atherosclerosis80. Furthermore, the median intake of fish oil in the lowest tertile in Japanese men was still greater than that of the highest tertile in American men, suggesting that, with respect to cIMT, fish oil intake has to reach a certain minimum before it becomes effective.

Potential mechanisms

Although both ectopic calcification and bone loss are conditions of ageing and are prevalent in smokers, type 2 diabetics, postmenopausal women and renal patients81, there have been numerous additional mechanisms proposed for their association, among which are chronic inflammation and oxidative stress, in particular elevated lipid oxidation products6,81. Oxidised LDL is known to inhibit osteoblast differentiation and mineralisation and promote mineralisation of vascular cells by increasing oxidative stress and receptor activator of nuclear factor kappa B ligand (RANKL)82, 83. Both ω6 and ω3 fats are prone to oxidation, while heating or processing may convert them to pro-inflammatory trans fats84, although little research has been carried out in this area with respect to bone or ectopic calcification. Fatty acids also metabolise to prostaglandins and cytokines, with ω6 fats generating pro-inflammatory cytokines via prostaglandin E2 and ω3 fats generating less inflammatory or anti-inflammatory cytokines via prostaglandin E3.

Conclusion

Ectopic calcification is often associated with osteoporosis and bone fracture, probably through the common mechanism of chronic inflammation and oxidative stress. Studies on fat intake and ectopic calcification are fewer than for bone but most animal studies show that a high total or saturated fat diet promotes ectopic calcification and lower BMD, while PUFAs, particularly fish oil and GLA, can decrease ectopic calcification and improve bone parameters. Human studies, however, show mixed results for total and saturated fats and PUFAs, although very high levels of any fat appears detrimental to both. Where there is a clear effect, the particular fat has the same beneficial or harmful effect on tissues and bone. Some of the reason for the lack of clarity of results may be that most studies only look for a linear relationship, whereas fatty acid intake may show a U-shaped dose/response curve. Although the ω6:ω3 ratio was not assessed in ectopic calcification, the highest bone formation rate occurred with a ratio of below 5:1. There may also be an interaction between types of PUFA, with fish oil plus high LA being detrimental in bone but fish oil plus high AA being beneficial. High PUFA intake also lowered BMD if calcium intake was low. While both ω6 and ω3 fats are necessary for bone, ω3 fats are generally more effective, with DHA being the active component of fish oil for bone health, while EPA appears more beneficial in arteries. Similarly, oily fish intake protects against CAC and bone loss and fracture. A high intake of total and saturated fats was also positively correlated with cIMT, another measure of subclinical atherosclerosis, while fish and fish oil were inversely associated; the association may be stronger for cIMT and soft plaque scores than for CAC.

References

1. 

Shanahan CM, Cary NR, Metcalfe JC et al ‘High espression of genes for calcification-regulating proteins in human atherosclerotic plaque’. J Clin Invest 1994; 93: 2393–2402

2. 

Nicoll R, Henein M Extensive coronary calcification: a clinically unrecognised condition. Curr Vasc Pharmacol 2010; Sep85701–5

3. 

El Maghraoui A, Rezqi A, Mounach A, Achemial L, Bezza A, Dehhaoui M, ghozlani I ‘Vertebral fractures and abdominal aortic calcification in postmenopausal women. A cohort study’. Bone 2013; Epub ahead of print

4. 

Hyder JA, Allison MA, Wong N, Papa A, Lang TF, Sirlin C, gapstur SM, Ouyang P, Carr JJ, Criqui MH Association of coronary artery and aortic calcium with lumbar bone density: the MESA Abdominal Aortic Calcium Study. Am J Epidemiol 2009; Jan151692186–94

5. 

Choi SH, An JH, Lim S, Koo BK, Park SE, Chang HJ, Choi SI, Park YJ, Park KS, Jang HC, Shin CS Lower bone mineral density is associated with higher coronary calcification and coronary plaque burdens by multidetector row coronary computed tomography in pre- and postmenopausal women. Clin Endocrinol (Oxf) 2009; Nov715644–51

6. 

Anagnostis P, Karagiannis A, Kakafika AI, Tziomalos K, Athyros Vg, Mikhailidis DP ‘Atherosclerosis and osteoporosis: age-dependent degenerative processes or related entities?’. Osteoporosis Int 2009; 20: 197–207

7. 

Danilevicius CF, Lopes JB, Pereira RM Bone metabolism and vascular calcification. Braz J Med Biol Res 2007; Apr404435–42

8. 

Burnett JR, Vasikaran SD Cardiovascular disease and osteoporosis: is there a link between lipids and bone?. Ann Clin Biochem 2002; May39Pt 3203–10

9. 

Bagger YZ, Rasmussen HB, Alexandersen P, Werge T, Christiansen C, Tanko LB PERF study group ‘Links between cardiovascular disease and osteoporosis in postmenopausal women: serum lipids or atherosclerosis per se?’. Osteoporos Int 2007; Apr184505–12

10. 

Xu J, Eilat-Adar S, Loria C, goldbourt U, Howard BV, Fabsitz RR, Zephier EM, Mattil C, Lee ET Dietary fat intake and risk of coronary heart disease: the Strong Heart Study. Am J Clin Nutr 2006; Oct844894–902

11. 

Oh K, Hu FB, Manson JE, Stampfer MJ, Willett WC Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the nurses’ health study. Am J Epidemiol 2005; Apr11617672–9

12. 

Hennig B, Toborek M, McClain CJ High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis. J Am Coll Nutr 2001 Apr; 20: 2 Suppl97–105

13. 

Lou-Bonafonte JM, Arnal C, Navarro MA, Osada J Efficacy of bioactive compounds from extra virgin olive oil to modulate atherosclerosis development. Mol Nutr Food Res 2012; Jul5671043–57

14. 

von Schacky C, Angerer P, Kothny W, Theisen K, Mudra H The effect of dietary w-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1999; Apr61307554–62

15. 

Serikawa T, Miura SI, Okabe M, Hongo H, Tokutome M, Yoshikawa T et al ‘The ratio of eicosapentaenoic acid to arachidonic acid is a critical risk factor for acute coronary syndrome in middle-aged older patients as well as younger adult patients’. J Cardiol 2014; Jan63135–40

16. 

Kummerow FA, Zhou Q, Mahfouz MM ‘Effect of trans fatty acids on calcium influx into human arterial endothelial cells’. Am J Clin Nutr 1999; 705832–8

17. 

Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res 2006; Mar31986727–9

18. 

Musacchio E, Priante g, Budakovic A, Baggio B Effects of unsaturated free fatty acids on adhesion and on gene expression of extracellular matrix macromolecules in human osteoblast-like cell cultures. Connect Tissue Res 2007; 48134–8

19. 

Kim Y, Kelly OJ, Ilich JZ ‘Synergism of w-linolenic acid, conjugated linoleic acid and calcium in decreasing adipocyte and increasing osteoblast cell growth’. Lipids 2013; Aug488787–802

20. 

Drolet MC, Couet J, Arsenault M ‘Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium’. J Heart Valve Dis 2008; 174381–7

21. 

Hekimian g, Passefort S, Louedec L, Houard X, Jacob MP, Vahanian A et al ‘High-cholesterol + vitamin D2 regimen: a questionable in-vivo experimental model of aortic valve stenosis’. J Heart Valve Dis 2009; 182152–8

22. 

Rokita E, Cichocki T, Heck D, Jarczyk L, Strzalkowski A ‘Calcification of aortic wall in cholesterol-fed rabbits’. Atherosclerosis 1991; 8723183–93

23. 

Nguyen N, Naik V, Speer MY Diabetes mellitus accelerates cartilaginous metaplasia and calcification in atherosclerotic vessels of LDLr mutant mice. Cardiovasc Pathol 2013; MarApr222167–75

24. 

Schmiedl A, Schwille PO, Bonucci E, Erben Rg, grayczyk A, Sharma V ‘Nephrocalcinosis and hyperlipidemia in rats fed a cholesterol- and fat-rich diet: association with hyperoxaluria, altered kidney and bone minerals and renal tissue phospholipid-calcium interaction’. Urol Res 2000; 286404–15

25. 

Van den Broek FA, Beynen AC ‘Effect of dietary fat level on the calcium content of heart and kidney in DBA/2 and C57BL/6 mice’. Lab Anim 1998; 322206–13

26. 

Birt DF, Pour PM Interaction of dietary fat and protein in spontaneous diseases of Syrian golden hamsters. J Natl Cancer Inst 1985; Jul751127–33

27. 

Burgess NA, Reynolds TM, Williams N, Pathy A, Smith S Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res 1995; 234239–42

28. 

Kanai S, Uto K, Honda K, Hagiwara N, Oda H Eicosapentaenoic acid reduces warfarin-induced arterial calcification in rats. Atherosclerosis 2011; Mar215143–51

29. 

Schlemmer CK, Coetzer H, Claassen N, Kruger MC, Rademeyer C, van Jaarsveld L, Smuts CM ‘Ectopic calcification of rat aortas and kidneys is reduced with n-3 fatty acid supplementation’. Prostaglandins Leukot Essent Fatty Acids 1998; 593221–7

30. 

Corwin RL Effects of dietary fats on bone health in advanced age. Prostaglandins Leukot Essent Fatty Acids 2003; Jun686379–86

31. 

Sanderson JP, Binkley N, Roeker EB, Champ JE, Pugh TD, Aspnes L, Weindruch R 1997 Influence of fat intake and caloric restriction on bone in aging male rats. J gerontol A Biol Sci Med Sci 52A: B20–5

32. 

Wohl gR, Loehrke L, Watkins BA, Zernicke RF Effects of high-fat diet on mature bone mineral content, structure, and mechanical properties. Calcif Tissue Int 1998; Jul63174–9

33. 

Naghii MR, Ebrahimpour Y, Darvishi P, ghanizadeh g, Mofid M, Torkaman D et al ‘Effect of consumption of fatty acids, calcium, vitamin D and boron with regular physical activity on bone mechanical properties and corresponding metabolic hormones in rats’. Indian J Exp Biol 2012; 503223–31

34. 

Puel C, Quintin A, Agalias A, Mathey J, Obled C, Mazur A et al 2004; Olive oil and its main phenolic micronutrient (oleuropein) prevent inflammation-induced bone loss in the ovariectomised rat. Br J Nutr 92: 119–127

35. 

Lau BY, Fajardo VA, McMeekin L, Sacco SM, Ward WE, Roy BD et al Influence of high-fat diet from differential dietary sources on bone mineral density, bone strength, and bone fatty acid composition in rats. Appl Physiol Nutr Metab 2010; 35: 598–606

36. 

Boulbaroud S, Mesfioui A, Arfaoui A, Ouichou A, el-Hessni A Preventive effects of flaxseed and sesame oil on bone loss in ovariectomized rats. Pak J Biol Sci 2008; 11: 1696–1696

37. 

Cohen SL, Ward WE ‘Flaxseed oil and bone development in growing male and female mice’. J Toxicol Environ Health 2005; Part A68: 1861–1870

38. 

Baird HT, Eggett DL, Fullmer S Varying ratios of ω-6:ω-3 fatty acids on the pre-and postmortem bone mineral density, bone ash, and bone breaking strength of laying chickens. Poult Sci 2008; 87: 323–8

39. 

Sun L, Tamaki H, Ishimaru T et al Inhibition of osteoporosis due to restricted food intake by the fish oils DHA and EPA and perilla oil in the rat. Biosci Biotechnol Biochem 2004; 68: 2613–5

40. 

Sun D, Krishnan A, Khaliquz Z et al Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice. J Bone Miner Res 2003; 18: 1206–1216

41. 

Matsushita H, Barrios JA, Shea JE, Miller SC Dietary fish oil results in a greater bone mass and bone formation indices in aged ovariectomized rats. J Bone Miner Metab 2008; 26: 241–7

42. 

Ahmed MA, Abd el Samad AA ‘Benefits of omega-3 fatty acid against bone changes in salt-loaded rats: possible role of kidney’. Physiol Rep 2013; Oct15e00106

43. 

Judex S, Wohl GR, Wolff RB, Leng W, Gillis AM, Zernicke RF ‘Dietary fish oil supplementation adversely affects cortical bone morphology and biomechanics in growing rabbits’. Calcif. Tissue Int 2000; 666443–448

44. 

Watkins BA, Li Y, Seifert MF ‘Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomised rats’. J Nutr Biochem 2006; 174282–9

45. 

Watkins BA, Li Y, Allen KG, Hoffmann WE, Seifert MF ‘Dietary ratio of (n-6)/ (n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats’. J Nutr 2000; 13092274–84

46. 

Blank C, Neumann MA, Makrides M, Gibson RA Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio. J. Lipid Res 432002; 1537–1543

47. 

Sakaguchi K, Morita I, Murota S Eicosapentaenoic acid inhibits bone loss due to ovariectomy in rats. Prostaglandins Leukotrienes Essent Fatty Acids 1994; 50: 81–84

48. 

Kruger MC, Schollum LM Is docosahexaenoic acid more effective than eicosapentaenoic acid for increasing calcium bioavailability?. Prostaglandins Leukot Essent Fatty Acids 2005; Nov735327–34

49. 

Poulsen RC, Kruger MC Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats. Prostaglandins Leukot Essent Fatty Acids 2006; 75: 419–27

50. 

Claassen N, Potgieter HC, Seppa M, Vermaak WJ, Coetzer H, Van Papendorp DH, Kruger MC Supplemented gamma-linolenic acid and eicosapentaenoic acid influence bone status in young male rats: effects on free urinary collagen crosslinks, total urinary hydroxyproline, and bone calcium content. Bone 1995; Apr164 Suppl385S–392S

51. 

Poulsen RC, Firth EC, Rogers CW, Moughan PJ, Kruger MC Specific effects of gamma-linolenic, eicosapentaenoic, and docosahexaenoic ethyl esters on bone post-ovariectomy in rats. Calcif Tissue Int 2007; Dec816459–71

52. 

Lucia VD, Fitzpatrick-Wong SC, Weiler HA Dietary arachidonic acid suppresses bone turnover in contrast to low dosage exogenous prostaglandin E(2) that elevates bone formation in the piglet. Prostaglandins Leukot Essent Fatty Acids 2003; Jun686407–13

53. 

Mollard RC, Kovacs HR, Fitzpatrick-Wong SC, Weiler HA Low levels of dietary arachidonic and docosahexaenoic acids improve bone mass in neonatal piglets, but higher levels provide no benefit. J Nutr 2005; Mar1353505–12

54. 

Oh KW, Nam CM, Jee SH, Choe KO, Suh I Coronary artery calcification and dietary cholesterol intake in Korean men. Acta Cardiol 2002; Feb5715–11

55. 

Park HA, Lee JS, Kuller LH Relationship between premenopausal dietary intake and postmenopausal subclinical atherosclerosis. Atherosclerosis 2006; Jun1862420–7

56. 

Snell-Bergeon JK, Chartier-Logan C, Maahs DM, Ogden LG, Hokanson JE, Kinney GL, Eckel RH, Ehrlich J, Rewers M Adults with type 1 diabetes eat a high-fat atherogenic diet that is associated with coronary artery calcium. Diabetologia 2009; May525801–9

57. 

Son YK, Lee SM, Kim SE, Kim KH, Lee SY, Bae HR, Han JY, Park Y, An WS Association between vascular calcification scores on plain radiographs and fatty acid contents of erythrocyte membrane in hemodialysis patients. J Ren Nutr 2012; Jan22158–66

58. 

He K, Liu K, Daviglus ML, Mayer-Davis E, Jenny NS, Jiang R, Ouyang P, Steffen LM, Siscovick D, Wu C, Barr RG, Tsai M, Burke GL Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008; Oct8841111–8

59. 

Sekikawa A, Curb JD, Ueshima H et al Marine-derived n23 fatty acids and atherosclerosis in Japanese, Japanese-American, and white men. J Am Coll Cardiol 2008; 52: 417–24

60. 

Sekikawa A, Miura K, Lee S, Fujiyoshi A, Edmundowicz D, Kadowaki T ‘Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study’. Heart 2013; Epub ahead of print

61. 

Ueeda M, Doumei T, Takaya Y, Shinohata R, Katayama Y, Ohnishi N, Takaishi A, Miyoshi T, Hirohata S, Kusachi S Serum N-3 polyunsaturated fatty acid levels correlate with the extent of coronary plaques and calcifications in patients with acute myocardial infarction. Circ J 2008; Nov72111836–43

62. 

Heine-Bröring RC, Brouwer IA, Proença RV, van Rooij FJ, Hofman A, Oudkerk M, Witteman JC, Geleijnse JM Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr 2010; May9151317–23

63. 

Martinez-Ramirez MJ, Palma S, Martinez-Gonzalez MA, Delgado-Martinez AD, de la Fuente C, Delgado-Rodriguez M 2007 Dietary fat intake and the risk of osteoporotic fractures in the elderly. Eur J Clin Nutr 61: 1114–1120

64. 

Orchard TS, Cauley JA, Frank GC, Neuhouser ML, Robinson JG, Snetselaar L, Tylavsky F, Wactawski-Wende J, Young AM, Lu B, Jackson RD 2010Fatty acid consumption and risk of fracture in the Women’s Health Initiative. Am J Clin Nutr 92: 1452–1460

65. 

Corwin RL, Hartman TJ, Maczuga SA et al Dietary saturated fat intake is inversely associated with bone density in humans: Analysis of NHANES III. J Nutr 2006; 136: 159–165

66. 

Macdonald HM, New SA, Golden MH, Campbell MK, Reid DM Nutritional associations with bone loss during the menopausal transition: evidence of a beneficial effect of calcium, alcohol, and fruit and vegetable nutrients and of a detrimental effect of fatty acids. Am J Clin Nutr 2004; 79: 155–65

67. 

Järvinen R, Tuppurainen M, Erkkilä AT, Penttinen P, Kärkkäinen M, Salovaara K, Jurvelin JS, Kröger H Associations of dietary polyunsaturated fatty acids with bone mineral density in elderly women. Eur J Clin Nutr 2012; Apr664496–503

68. 

Virtanen JK, Mozaffarian D, Willett WC, Feskanich D Dietary intake of polyunsaturated fatty acids and risk of hip fracture in men and women. Osteoporos Int 2012; Nov23112615–24

69. 

Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL Dietary intakes of arachidonic acid and alpha-linolenic acid are associated with reduced risk of hip fracture in older adults. J Nutr 2011; Jun14161146–53

70. 

Virtanen JK, Mozaffarian D, Cauley JA, Mukamal KJ, Robbins J, Siscovick DS Fish consumption, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. J Bone Miner Res 2010; Sep2591972–9

71. 

Farina EK, Kiel DP, Roubenoff R, Schaefer EJ, Cupples LA, Tucker KL Protective effects of fish intake and interactive effects of long-chain polyunsaturated fatty acid intakes on hip bone mineral density in older adults: the Framingham Osteoporosis Study. Am J Clin Nutr 2011; May9351142–51

72. 

Chen YM, Ho SC, Lam SS Higher sea fish intake is associated with greater bone mass and lower osteoporosis risk in postmenopausal chinese women. Osteoporos Int 2010; 216939–46

73. 

Suzuki T, Yoshida H, Hashimoto T et al Case-control study of risk factors for hip fractures in the Japanese elderly by a Mediterranean osteoporosis Study (Medos) questionnaire. Bone 1997; 21: 461–467

74. 

Griel AE, Kris-Etherton PM, Hilpert KF et al 2007; An increase in dietary n-3 fatty acids decreases a marker of bone resorption in humans. Nutr J 6: 2

75. 

Martin-Bautista E, Munoz-Torres M, Fonolla J, Quesada M, Poyatos A, Lopez-Huertas E Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins. Nutr Res 2010; 30: 320–6

76. 

Salari Sharif P, Asalforoush M, Ameri F, Larijani B, Abdollahi M The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial. Age (Dordr) 2010; 32: 179–86

77. 

Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal v. calcium alone. Br J Nutr 2000; 83: 629–629

78. 

Lucey AJ, Paschos GK, Cashman KD, Martinéz JA, Thorsdottir I, Kiely M 2008Influence of moderate energy restriction and seafood consumption on bone turnover in overweight young adults. Am J Clin Nutr 87: 1045–1052

79. 

Appleton KM, Fraser WD, Rogers PJ et al 2011; Supplementation with a low-moderate dose of n-3 long-chain PUFA has no short-term effect on bone resorption in human adults. The British journal of nutrition 105: 81145–1149

80. 

Jensky NE, Hyder JA, Allison MA, Wong N, Aboyans V, Blumenthal RS, Schreiner P, Carr JJ, Wassel CL, Ix JH, Criqui MH The association of bone density and calcified atherosclerosis is stronger in women without dyslipidemia: the multi-ethnic study of atherosclerosis. J Bone Miner Res 2011; Nov26112702–9

81. 

Hofbauer LC, Brueck CC, Shanahan CM, Schoppet M, Dobnig H Vascular calcification and osteoporosis--from clinical observation towards molecular understanding. Osteoporos Int 2007; Mar183251–9

82. 

Demer LL ‘Vascular calcification and osteoporosis: inflammatory responses to oxidised lipids’. Int J Epidemiol 2002; 31: 737–741

83. 

Maziere C, Salle V, Gomila C, Maziere JC ‘Oxidised low density lipoprotein increases RANKL level in human vascular cells. Involvement of oxidative stress.’. Biochem Biophys Res Commun 2013; Epub ahead of print

84. 

Kummerow FA The negative effects of hydrogenated trans fats and what to do about them. Atherosclerosis 2009; Aug2052458–65



Copyright (c) 2015 Rachell nicoll

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.